NCT00825994View on ClinicalTrials.gov

Omega-3 for Peri- and Postmenopausal Depression

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Depression
Interventions
DRUG

Omega-3 Fatty Acids

2 g omega-3 fatty acids (docosahexaenoic acid \[DHA\] + eicosapentaenoic acid \[EPA\]), PO \[by mouth\], qd \[every day\]

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Massachusetts General Hospital

OTHER